Forbes Magazine has named Generate:Biomedicines to the fourth annual Forbes AI 50 List, which recognizes standouts in privately-held North American companies making the most interesting and effective use of artificial intelligence technology. Generate is one of only five pharmaceutical companies named to the list. Forbes compiles an annual list to spotlight the most promising startups that are emerging as leaders in this space.
The Forbes AI 50 list was compiled through a submission process open to any company developing technology that enables machines to learn from experience or new data or perform human-like tasks such as recognizing speech or images, classifying information, and predicting outcomes.